Transversus Abdominis Plan Block, Ultrasound or Laparoscopic?

Ankara City Hospital

Status: Completed

Conditions: Anesthetics; Peripheral Nervous System Agents; Bupivacaine; Anesthetics, Local

Treatments: Drug: bupivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT04634721

Ultrasound or Laparoscopic TAP

Details and patient eligibility

About

Abdominal wall blocks are frequently used as part of multimodal analgesia for pain control after abdominal surgery. There are studies using the Transversus Abdominis Plane Block for postoperative pain control in laparoscopic cholecystectomies.

In this study, the investigators aimed to compare the advantages of these two methods by applying the Transversus Abdominis Plan Block for postoperative pain control after laparoscopic cholecystectomy with the help of postoperative USG and laparoscopy during surgery.In this study, the investigators aimed to compare the advantages of these two methods by applying the Transversus Abdominis Plan Block for postoperative pain control after laparoscopic cholecystectomy with the help of postoperative USG and LAPAROSCOPY during surgery.

Full description

A total of 60 patients aged 18-65, ASA 1-2-3, who will undergo elective laparoscopic cholecystectomy in our hospital, will be included in the study. Patients will be randomly divided into 3 groups with ultrasound (USG) guided (GROUP 1: USG) , Laparoscopic application (GROUP 2: LAP) and GROUP 3 :No-TAP blok Each group consists of 20 evil people. Written consent will be obtained by explaining the procedure to be performed before the operation to the patients. The Transversus Abdominis Plan Block will be applied to the patients by a blind anesthesiologist according to their group. The block to be made by the anesthesiologist who will apply the block procedure will be given in a closed envelope.

Enrollment: 60 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA I,II,III
• Patients 18-65
• laparoscopic cholecystectomy

Exclusion criteria

• ASA III higher
• history of pain relief medication dependence
• history of substance abuse
• end stage chronic kidney disease
• advanced liver disease
• history of chronic pain -history of taking opioids or neuropathic agents regularly prior to surgery-
• BMI of 50 or over
• skin infections at the site of TAP block injection or port sites.

Trial design

Primary purpose: Other

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 3 patient groups

Laparoscopic TAP block

Active Comparator group

Description:

Laparoscopic assisted TAP block will be done by surgeon intra-operatively

Treatment:

Drug: bupivacaine

Ultrasaund TAP block

Active Comparator group

Description:

injecting bupivacaine in transversus abdominis plane to block the somatic nerves

Treatment:

Drug: bupivacaine

no TAP block

No Intervention group

Description:

no TAP block would be done